By the time Deb Dellapena arrived for work at Merck & Co.’s 90-acre campus north of Philadelphia, there was a...
Articles by Riley Griffin, Katherine Chiglinsky and David Voreacos, Bloomberg
Johnson & Johnson’s Janssen unit was hit with an $8 billion punitive-damages verdict — the largest jury award in the...
The Cleveland judge overseeing more than 2,000 federal lawsuits over alleged opioid abuses refused to disqualify himself from a bellwether...
While some Johnson & Johnson investors were relieved that the company’s $572 million penalty for fueling Oklahoma’s opioid epidemic wasn’t...
Endo International Plc agreed to an $11 million settlement to avoid going to trial in the first federal court cases...
Johnson & Johnson said that the health-care conglomerate will come out on the winning side of thousands of legal claims...
Drugmaker Insys Therapeutics Inc., whose former executives were convicted of bribing doctors to prescribe its highly addictive opioid, filed for...
Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay...
Insys Therapeutics Inc. founder John Kapoor was convicted of a racketeering conspiracy that drove sales of a highly addictive opioid...